Acute Upper Respiratory Tract Infections Clinical Trial
Official title:
Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
The purpose of this study is:
- to assess safety of the liquid dosage form of Ergoferon for treatment of acute upper
respiratory tract infections in children;
- to assess clinical efficacy of the liquid dosage form of Ergoferon for treatment acute
upper respiratory tract infections in children.
The overall duration of a patient's participation in the trial is 6 days (screening/randomization, therapy onset - day 1; study therapy period - 5 days; follow-up period-1 day). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02732847 -
Trial of Post-Dated Delayed Antibiotic Prescriptions
|
N/A | |
| Completed |
NCT00887172 -
Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)
|
Phase 4 | |
| Completed |
NCT00228254 -
Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study
|
Phase 4 | |
| Completed |
NCT01151202 -
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"
|
Phase 3 | |
| Completed |
NCT01765920 -
Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults
|
Phase 3 |